ADHD medication use following FDA risk warnings

Journal of Mental Health Policy and Economics

Volumn 15, Issue 3, 2012, Pages 119-125

  Barry, Colleen L ^a   Martin, Andres ^b   Busch, Susan H ^c  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c YALE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; CENTRAL STIMULANT AGENT;

ADOLESCENT; ADULT; ARTICLE; ATTENTION DEFICIT DISORDER; CHILD; CONTENT ANALYSIS; CONTROLLED STUDY; DRUG SAFETY; DRUG USE; EDUCATIONAL STATUS; FEMALE; FOOD AND DRUG ADMINISTRATION; HEALTH SURVEY; HOUSEHOLD; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; MASS MEDIUM; NEWBORN; PARENT; PRESCHOOL CHILD; PRESCRIPTION; PUBLICATION; RISK BENEFIT ANALYSIS; RISK FACTOR; SCHOOL CHILD; SUICIDAL BEHAVIOR; TELEVISION; CHEMICALLY INDUCED DISORDER; DRUG UTILIZATION; HEART DISEASE; MENTAL DISEASE; PATIENT SAFETY; SOCIOECONOMICS; STATISTICS; UNITED STATES;

ADOLESCENT; ADULT; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CENTRAL NERVOUS SYSTEM STIMULANTS; CHILD; CHILD, PRESCHOOL; DRUG UTILIZATION; FEMALE; HEART DISEASES; HUMANS; INFANT; MALE; MASS MEDIA; MENTAL DISORDERS; PATIENT SAFETY; SOCIOECONOMIC FACTORS; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION;

EID: 84867674603     PISSN: 10914358     EISSN: 1099176X     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Bloom B, Cohen RA. Summary Health Statistics for U.S. Children: National Health Interview Survey, 2006. National Center for Health Statistics. Vital Health Stat 10(234). 2007.
2. Strine TW, Lesesne CA, Okoro CA, McGuire LC, Chapman DP, Balluz LS, Mokdad AH. Emotional and Behavioral Difficulties and Impairments in Everyday Functioning Among Children With a History of Attention-Deficit/Hyperactivity Disorder. Prev Chronic Dis 2006; 3(2): A52.
3. The MTA Cooperative Group. A 14-Month Randomized Clinical Trial of Treatment Strategies for Attention-Deficit/Hyperactivity Disorder. Arch Gen Psychiatry 1999; 56: 1073-1086.
4. Sonni A. Statistical Brief: Attention-Deficit Hyperactivity Disorder (ADHD) in Children, Ages 5-17: Use and Expenditures. Medical Expenditure Panel Survey, Agency for Healthcare Research and Quality, 2009.
5. Olfson M, Marcus SC, Weissman MM, Mensen PS. National Trends in the Use of Psychotropic Medications by Children. J Am Acad Child Adolesc Psychiatry 2002; 41(5):514-521. (Pubitemid 38338129)
6. Zuvekas SH, Vitiello B, Norquist GS. Recent Trends in Stimulant Medication Use Among U.S. Children. Am J Psychiatry 2006; 163(4): 579-585 (Pubitemid 44464565)
7. Busch SH, Frank RG, Leslie DL, Martin A, Rosenheck RA, Martin EG, Barry CL. Antidepressants and Suicide Risk: How Did Specific Information in FDA Safety Warnings Affect Treatment Patterns? Psychiatr Serv 2009; 61(1): 11-16.
8. Gibbons RD, Brown CH, Hur K, Marcus SM, Bhaumik DK, Erkens JA, Herings RM, Mann JJ. Early evidence on the effects of regulators' suicidality warnings on SSRI prescriptions and suicide in children and adolescents. Am J Psychiatry 2007; 164(9): 1356-1363. (Pubitemid 47461135)
9. Libby AM, Brent EH, Morrato EH, Orton HD, Allen R, and Valuck RJ. (2007). Decline in treatment of pediatric depression after FDA advisory on risk of suicidality with SSRIs. Am J Psychiatry 2007; 164(6): 884-891. (Pubitemid 46972903)
10. Nemeroff CB, Kalali A, Keller MB, Charney DS, Lenderts SE, Cascade EF, Stephenson H, Schatzberg AF. Impact of publicity concerning pediatric suicidality data on physician practice patterns in the United States. Arch Gen Psychiatry 2007; 64(4): 466-472. (Pubitemid 46556464)
11. Olfson M, Marcus SC and Druss BG. Effects of Food and Drug Administration warnings on antidepressant use in a national sample. Arch Gen Psychiatry 2008; 65(1): 94-101.
12. Valluri S, Zito JM, Safer DJ, Zuckerman IH, Mullins CD, Korelitz JJ. Impact of the 2004 Food and Drug Administration Pediatric Suicidality Warning on Antidepressant and Psychotherapy Treatment for New-Onset Depression. Med Care 2010; 48(11):947-954.
13. Busch SH, Martin A, Frank RG, Barry CL. Characterizing declines in pediatric antidepressant use after new risk disclosures. Med Care Res Rev 2011; 61(1): 96-111.
14. Kaiser Family Foundation/Harvard School of Public Health. September/October 2001 Health News Index. Menlo Park, CA: Kaiser Family Foundation; 2001.
15. Dentzer S. Communicating Medical News: Pitfalls of Health Care Journalism. N Engl J Med 2009 Jan 1; 360(1): 1-3.
16. Barry CL, Busch SH. News Media Coverage of FDA Warnings on Pediatric Antidepressant Use and Suicidality. Pediatrics 2010; 125 (1): 88-95.
17. http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/2007/ucm108849. htm accessed on November 7, 2010.
18. Selden TM, Levit KR, Cohen JW, Zuvekas SH, Moeller JF, McKusick D, Arnett RH 3rd. Reconciling medical expenditure estimates from the MEPS and the NHA, 1996. Health Care Financ Rev 2001; 23(1):161-178. (Pubitemid 33139556)
19. Zuvekas SH. Prescription Drugs and the Changing Patterns of Treatment for Mental Disorders, 1996-2001. Health Aff 2005; 24(1): 195-205. (Pubitemid 40169788)
20. Cascade E, Kalali AH, Weisler RH, Lenderts S. Seasonality and the Changing Adult/Child Prescription Ratios in ADHD Therapy. Psychiatry 2008; 5(1): 23-25.